These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. WHO expert committee on leprosy. World Health Organ Tech Rep Ser; 1970; 459():3-31. PubMed ID: 4993944 [No Abstract] [Full Text] [Related]
26. [Hansen's disease - evolution of ideas]. Colin M Acta Leprol; 1981; (83):41-51. PubMed ID: 6792856 [No Abstract] [Full Text] [Related]
27. Treating Hansen's disease in developing countries. Jackson T West J Med; 1994 Mar; 160(3):278; author reply 279-80. PubMed ID: 8031394 [No Abstract] [Full Text] [Related]
28. Therapy of leprosy. Convit J; Browne SG; Languillon J; Pettit JH; Ramanujam K; Sagher F; Sheskin J; Tarabini G; de Souza Lima L; Tolentino JG; Waters MF; Bechelli LM; Martínez Domínguez V Bull World Health Organ; 1970; 42(5):667-72. PubMed ID: 5311056 [TBL] [Abstract][Full Text] [Related]
29. [In vitro immunologic changes in 4 patients with lepromatous leprosy treated for 1 year with rifampicin and sulfones and left untreated the following year]. Saint-André P Acta Leprol; 1979; (76-77):301-2. PubMed ID: 121849 [No Abstract] [Full Text] [Related]
30. [Tuberculoid development of a lepromatous form of Hansen's disease treated with a derivative of thiourea (Ciba 1906)]. Témime P; Privat Y; Benne M Bull Soc Fr Dermatol Syphiligr; 1966; 73(3):285-6. PubMed ID: 5962550 [No Abstract] [Full Text] [Related]
31. [Hansen's disease: case report and review of literature]. Concha R M; Cossio T ML; Salazar S I; Fich S F; Pérez C C; González B S Rev Chilena Infectol; 2008 Feb; 25(1):64-9. PubMed ID: 18273528 [TBL] [Abstract][Full Text] [Related]
32. Short report: Treatment failure in Hansen's disease. Murray CK; Joyce MP; Longfield RN Am J Trop Med Hyg; 2003 Feb; 68(2):233-4. PubMed ID: 12641417 [TBL] [Abstract][Full Text] [Related]
33. [Comparative study of the therapeutic activity of glutamic acid phthalimide and the therapeutic activity of triamcinolone in the treatment of Hansen's reaction of Virchowian Leprosy]. de Almeida Neto E Hansenol Int; 1981 Dec; 6(2):114-21. PubMed ID: 6759397 [TBL] [Abstract][Full Text] [Related]
34. The drug treatment of leprosy. Browne SG Trans R Soc Trop Med Hyg; 1967; 61(2):265-71. PubMed ID: 6047760 [No Abstract] [Full Text] [Related]
35. [Hansen's disease and my work]. Saikawa K Nihon Rai Gakkai Zasshi; 1989; 58(1):26-7. PubMed ID: 2745243 [No Abstract] [Full Text] [Related]
36. The treatment of leprosy with the sulfones. I. Faget's original 22 patients. A thirty-year follow-up on sulfone therapy for leprosy. Jacobson RR; Trautman JR Int J Lepr Other Mycobact Dis; 1971; 39(3):726-37. PubMed ID: 4948221 [No Abstract] [Full Text] [Related]
37. [Treatment of leprosy by sulfones and delayed action sulfonamides. Comparison of therapeutic results in 100 cases]. Faye I; Privat Y; Bellossi A Bull Soc Med Afr Noire Lang Fr; 1968; 13(1):119-24. PubMed ID: 5713742 [No Abstract] [Full Text] [Related]
38. The condition of the peripheral nerve in leprosy under various forms of treatment. Conduction velocity studies in long-term follow-up. Magora A; Sheskin J; Sagher F; Gonen B Int J Lepr Other Mycobact Dis; 1970; 38(2):149-63. PubMed ID: 5529246 [No Abstract] [Full Text] [Related]
39. Recent experience with thalidomide in Hansen's Disease. Sheskin J Int J Dermatol; 1970; 9(1):56-8. PubMed ID: 4912951 [No Abstract] [Full Text] [Related]
40. Reversal reaction to Hansen's disease. Jih MH; Kimyai-Asadi A; Levis WR J Drugs Dermatol; 2002 Jul; 1(1):70-1. PubMed ID: 12847760 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]